Synergistic Design Rather than relying on a single compound, ColonBroom combines these ingredients to influence GLP-1 activity from multiple angles
You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider
HELP & SUPPORT Frequently Asked Questions How does Queen RX Work
In October 2024, Amneal Pharma invested Rs 1,600 crore in Gujarat to manufacture GLP-1 drugs
Tirzepatide, a newer dual GLP-1 and GIP receptor agonist, shows enhanced weight loss compared to semaglutide alone in clinical trials
Administration: Once-weekly injection